|
Volumn 53, Issue 3, 2001, Pages 285-305
|
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors
|
Author keywords
Doxorubicin; FaDu tumors; Hyperthermia; Liposomes; Lysolipid
|
Indexed keywords
DISEASE CONTROL;
LIPIDS;
TESTING;
TUMORS;
DRUG DELIVERY SYSTEM;
DRUG THERAPY;
1,2 DIPALIMITOYL SN GLYCERO 3 PHOSPHOCHOLINE;
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
DRUG CARRIER;
LIPOSOME;
MACROGOL 2000;
MELPHALAN;
METHOTREXATE;
PHOSPHOLIPASE A2;
UNCLASSIFIED DRUG;
BODY TEMPERATURE;
CANCER CHEMOTHERAPY;
CONTROLLED DRUG RELEASE;
DRUG ACCUMULATION;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG SCREENING;
DRUG TISSUE LEVEL;
DRUG UPTAKE;
HEAT TREATMENT;
HUMAN;
HYPERTHERMIA;
LIPID BILAYER;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SKIN FLAP;
SOLID TUMOR;
TARGET CELL;
TEMPERATURE SENSITIVITY;
TUMOR GROWTH;
TUMOR MODEL;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
HUMANS;
LIPID BILAYERS;
LIPOSOMES;
TEMPERATURE;
|
EID: 0035981024
PISSN: 0169409X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-409X(01)00233-2 Document Type: Review |
Times cited : (503)
|
References (72)
|